Orot, Ricky C.

HRN: 27-35-43  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/20/2025
07/03/2025
IV
600mg
Q6h
Infected Wound
Checking Initial Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines